Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6

Clin Mol Hepatol. 2013 Mar;19(1):45-50. doi: 10.3350/cmh.2013.19.1.45. Epub 2013 Mar 25.

Abstract

Background/aims: The distribution of hepatitis C virus (HCV) genotypes varies geographically. In Korea, genotypes 1 and 2 comprise more than 90% of HCV infections, while genotype 6 is very rare. This study compared the clinical and epidemiological characteristics of patients with genotype 6 HCV infection with those infected with HCV genotypes 1 and 2.

Methods: This was a prospective, multicenter HCV cohort study that enrolled 1,173 adult patients, of which 930 underwent HCV genotype analysis, and only 9 (1.0%) were found to be infected with genotype 6 HCV. The clinical and epidemiological parameters of the genotypes were compared.

Results: The patients with genotype 6 HCV had a mean age of 41.5 years, 77.8% were male, and they had no distinct laboratory features. A sustained virologic response (SVR) was observed in four (67%) of six patients who received antiviral therapy. Risk factors such as the presence of a tattoo (n=6, 66.7%), more than three sexual partners (n=3, 33.3%), and injection drug use (n=3, 33.3%) were more common among genotype 6 patients than among genotypes 1 or 2.

Conclusions: The epidemiology and treatment response of patients infected with genotype 6 HCV differed significantly from those with genotypes 1 or 2, warranting continuous monitoring.

Keywords: Epidemiology; Genotype; HCV; Korea; Treatment.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antiviral Agents / therapeutic use
  • Asian People
  • Cohort Studies
  • Female
  • Genotype
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / diagnosis*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Liver / pathology
  • Male
  • Middle Aged
  • Prospective Studies
  • RNA, Viral / blood
  • Republic of Korea
  • Risk Factors
  • Sexual Behavior
  • Substance-Related Disorders / complications
  • Tattooing

Substances

  • Antiviral Agents
  • RNA, Viral